These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9183312)
1. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study. Hainaut P; Azerad MA; Lehmann E; Schlit AF; Zech F; Heusterspreute M; Philippe M; Col C; Lavenne E; Moriau M J Intern Med; 1997 May; 241(5):427-33. PubMed ID: 9183312 [TBL] [Abstract][Full Text] [Related]
2. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565 [TBL] [Abstract][Full Text] [Related]
3. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients. Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856 [TBL] [Abstract][Full Text] [Related]
4. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance. Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576 [TBL] [Abstract][Full Text] [Related]
5. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism. Bennet L; Odeberg H J Intern Med; 1998 Jul; 244(1):27-32. PubMed ID: 9698021 [TBL] [Abstract][Full Text] [Related]
6. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401 [TBL] [Abstract][Full Text] [Related]
7. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia. De Stefano V; Leone G Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506 [TBL] [Abstract][Full Text] [Related]
8. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis. Svensson PJ; Zöller B; Mattiasson I; Dahlbäck B J Intern Med; 1997 May; 241(5):379-85. PubMed ID: 9183305 [TBL] [Abstract][Full Text] [Related]
9. Thrombotic risk factors and oral contraception. Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978 [TBL] [Abstract][Full Text] [Related]
10. [Resistance to activated protein C. The most common cause of familial thrombophilia]. Larsen TB; Ravn HB; Lassen JF; Lund ED; Brandslund I Ugeskr Laeger; 1996 Nov; 158(46):6584-8. PubMed ID: 8966822 [TBL] [Abstract][Full Text] [Related]
11. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance. van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263 [TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Ciardella AP; Yannuzzi LA; Freund KB; DiMichele D; Nejat M; De Rosa JT; Daly JR; Sisco L Retina; 1998; 18(4):308-15. PubMed ID: 9730172 [TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Price DT; Ridker PM Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of the factor V leiden mutation in children and neonates with thromboembolic disease. Hagstrom JN; Walter J; Bluebond-Langner R; Amatniek JC; Manno CS; High KA J Pediatr; 1998 Dec; 133(6):777-81. PubMed ID: 9842043 [TBL] [Abstract][Full Text] [Related]
15. Effects of oral contraceptives on hemostasis and thrombosis. Rosing J; Tans G Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524 [TBL] [Abstract][Full Text] [Related]
16. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Hellgren M; Svensson PJ; Dahlbäck B Am J Obstet Gynecol; 1995 Jul; 173(1):210-3. PubMed ID: 7631684 [TBL] [Abstract][Full Text] [Related]
17. No association between thrombosis and factor V gene polymorphisms in Chinese Han population. Yanqing H; Fangping C; Qinzhi X; Zaifu J; Guangping W; Xiaoxia Z; Xiaoqun P; Xiaobo Thromb Haemost; 2003 Mar; 89(3):446-51. PubMed ID: 12624626 [TBL] [Abstract][Full Text] [Related]
18. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561 [TBL] [Abstract][Full Text] [Related]
19. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Voorberg J; Roelse J; Koopman R; Büller H; Berends F; ten Cate JW; Mertens K; van Mourik JA Lancet; 1994 Jun; 343(8912):1535-6. PubMed ID: 7911872 [TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden. Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]